Last Updated: 19 Sep 2024
Executive Summary
BIO-Key International Inc. (BKYI) is a technology company that develops and markets biometric fingerprint identification technology and enterprise-ready identity access management solutions. The company has a market capitalization of $2.39 million and is currently trading at $1.21 per share.
Company Overview
BIO-Key International was founded in 1999 and is headquartered in Wall, New Jersey. The company's products are used by commercial, government, and educational clients in the United States and internationally. BIO-Key International has a strong track record of innovation and has been recognized for its technology by industry analysts and publications.
Fundamental Analysis
BIO-Key International's financial performance has been mixed in recent years. The company has reported losses in each of the past three years, and its revenue has declined in each of the past two years. However, the company's gross profit margin has improved in recent quarters, and its operating expenses have declined.
BIO-Key International's balance sheet is weak. The company has more liabilities than assets, and its equity is negative. The company's cash flow from operations has also been negative in recent years.
Technical Analysis
BIO-Key International's stock price has been in a downtrend since early 2022. The stock price is currently below its 50-day and 200-day moving averages. The stock's relative strength index (RSI) is also below 30, which indicates that the stock is oversold.
Short Term Outlook
BIO-Key International's stock price is likely to remain under pressure in the short term. The company's financial performance is weak, and its stock price is below its moving averages. The stock's RSI is also below 30, which indicates that the stock is oversold.
Long Term Outlook
BIO-Key International's long-term outlook is uncertain. The company's financial performance has been mixed in recent years, and its stock price has been in a downtrend. However, the company has a strong track record of innovation, and its technology has been recognized by industry analysts and publications.
Analyst Recommendations
The majority of analysts who cover BIO-Key International have a "hold" rating on the stock. The average analyst price target is $3.00 per share.
Conclusion
BIO-Key International is a technology company with a strong track record of innovation. However, the company's financial performance has been mixed in recent years, and its stock price has been in a downtrend. The company's long-term outlook is uncertain, and investors should proceed with caution.
